固体器官移植接受者的潜伏性结核病感染管理:全国快照
Aylin Özgen Alpaydın1, Tuba Yeter Turunç2, Vildan Avkan-Oğuz3
1Department of Pulmonary Diseases, Dokuz Eylül University School of Medicine, İzmir, Turkey.
Thoracic research and practice
|August 11, 2024
概括
在实体器官移植接受者中,移植前的潜伏性结核病感染查不足. 许多患有潜伏结核病的患者没有接受治疗或未登记,这凸显了需要改进风险评估和国家指导方针的需要.
科学领域:
- 移植医学 移植医学
- 传染病流行病学 传染病流行病学
- 公共卫生 公共卫生
背景情况:
- 潜伏性结核感染 (LTBI) 查对于实体器官移植 (SOT) 接受者至关重要.
- 全球许多移植中心的查率仍然低于最佳水平.
- 有效的LTBI管理对于预防移植后结核病至关重要.
研究的目的:
- 评估移植前结核病 (TB) 风险评估的现状.
- 评估在土耳其的SOT接收者中LTBI治疗和国家注册率.
- 为了确定当前LTBI管理协议中的漏洞.
主要方法:
- 对2015-2019年期间接受结核素皮肤测试 (TST) 和/或干扰素释试验 (IGRA) 的成年SOT接受者的回顾性研究.
- 从土耳其各地的14个移植中心收集的数据.
- 通过TST强化≥5毫米或阳性IGRA (QuantiFERON-TB) 定义的LTBI.
主要成果:
- 在2266名SOT接受者中,只有33.8%接受了LTBI的查.
- 在46.9%的查患者中检测到LTBI; 56.5%接受了异化治疗.
- 在接受治疗的人中,55.2%在全国注册,73.2%完成治疗. 结核病发生在1.06%的未接受治疗的患者中.
结论:
- 在土耳其,移植前结核病风险分层不足,仅有三分之一的SOT接受者被评估.
- 在SOT接收者中,LTBI的治疗和注册率低于最佳水平.
- 修订的国家准则对于改善SOT候选国结核病风险管理至关重要.
更多相关视频
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
18.8K
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
1.8K
相关概念视频
Pulmonary Tuberculosis V
176
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
176
Pulmonary Tuberculosis I
227
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
227
Pulmonary Tuberculosis IV
134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
Pulmonary Tuberculosis II
215
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
215
Pulmonary Tuberculosis III
316
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
316
Transmission-based Precautions II: Airborne and Protective Environment
1.2K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K
